Surgery and Interventional Science
- About Us
- Study Here
- Contact Us
Starts: Sep 18, 2014 9:00:00 AM
Implementing change into the Australian Healthcare System: Patient Blood Management - Dr Simon Towler, Chief Medical Officer, Western Australia
Starts: Sep 22, 2014 5:30:00 PM
Starts: Oct 2, 2014 9:00:00 AM
Tissue and Energy
Head of Research Department of Tissue and Energy: Dr Laurence Lovat
The Research Department of Tissue and Energy spans across the Bloomsbury campus, bringing together clinicians and scientists from a variety of backgrounds, who are working together to develop highly targeted novel imaging, sensing and energy based interventions to detect and cure disease.
At the Division of Surgery and Interventional Science's bases at UCLH and Charles Bell House, the Tissue and Energy research department is currently exploring a whole spectrum of technologies. These range from transforming the use of CT, MRI and ultrasound to developing completely new technologies using light and other forms of electromagnetic waves. From bench to bedside, the department is involved in the very earliest proof of concept studies within the laboratory, right through to large clinical trials on the hospital ward.
Next generation surgical interventions will use minimally invasive approaches
Within the Tissue and Energy research department, the major research groups are those of Professor Mark Emberton, who is blazing a new path for patients with prostate cancer, Professor Jayant Vaidya, whose endeavours have completely revolutionised the treatment of breast cancer and Dr Laurence Lovat whose work at the National Medical Laser Centre changed the management of pre-cancerous Barrett's oesophagus and is now focusing on changing the management of oesophageal cancer. The Clinical Trials Group, headed by Dr Chris Brew-Graves, coordinates the clinical translational studies which are at the very heart of the department's work.
All of the research groups have an interest in novel technologies and biomarkers of risk, which can also be used as therapeutic targets. Our new integrated molecular and cell science laboratory, which is headed by Dr Rifat Hamoudi, will help us to improve our targeting strategies for imaging and therapy for disease.
Over the next few years, the research group leaders aim to create a unique image guided diagnosis and therapy centre, which will combine the Tissue and Energy research department's clinical translational expertise, with that of the UCL Department of Medical Physics and Bioengineering. This will create a world-leading centre for developing novel, minimally invasive approaches to surgical intervention.
Strong working relationships generate new networks and further novel research ideas and outputs. Junior colleagues within the department are actively encouraged to forge these relationships both within UCL and with strategic partners beyond, whilst always focusing on the ultimate goal of bringing benefits to those who are sick.